Background This retrospective study investigated overall survival (OS) and factors
influencing OS in Swedish patients with metastatic renal cell carcinoma (mRCC) during the …

Introduction Treatment advances in metastatic renal cell carcinoma (mRCC) have improved
overall survival (OS) in mRCC patients over the last two decades. This single center …

Background This population-wide retrospective, non-interventional registry study assessed
changes in overall survival (OS) and factors influencing OS in Norwegian patients with renal …

Aim To evaluate the implementation of targeted therapy on overall survival (OS) in a
complete national cohort of patients with metastatic renal cell carcinoma (mRCC). Methods …

Background Real‐world data describing outcomes of treatment among metastatic renal cell
carcinoma (mRCC) patients are limited and heterogeneous. Aim RENSUR3 registry study …

20 Background: The results of the 5-year overall survival (OS) in patients with metastatic
renal cell carcinoma (mRCC) has been reported rarely. The aim of the RENSUR5 registry …

Background The 5-year overall survival (OS) of patients with metastatic renal cell carcinoma
(mRCC) has been rarely reported. The aim of the RENSUR5 registry study was to obtain …

BACKGROUND: Renal cell carcinoma (RCC) is the sixth leading cause of death in
developed countries. A third of all RCC patients are confronted with metastatic disease …

Background: This retrospective register study assessed overall survival (OS) and influential
factors on OS in Swedish renal cell carcinoma (RCC) patients. Methods: Using three merged …

Objective To examine the effect of diagnosis year, defined as contemporary (2010–2014),
intermediate (2006–2009) and historical (2001–2005) on cancer-specific mortality (CSM) in …